| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients
|
Cairo, Stefano
|
|
|
141 |
C |
p. 30-39
|
artikel
|
| 2 |
Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients
|
Acem, Ibtissam
|
|
|
141 |
C |
p. 128-136
|
artikel
|
| 3 |
Association of steroid use with survival in solid tumours
|
Petrelli, Fausto
|
|
|
141 |
C |
p. 105-114
|
artikel
|
| 4 |
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
|
Yekedüz, Emre
|
|
|
141 |
C |
p. 92-104
|
artikel
|
| 5 |
Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)
|
Tao, Yungan
|
|
|
141 |
C |
p. 21-29
|
artikel
|
| 6 |
Censored patients in Kaplan–Meier plots of cancer drugs: An empirical analysis of data sharing
|
Rosen, Kate
|
|
|
141 |
C |
p. 152-161
|
artikel
|
| 7 |
Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer
|
Peng, Xingzhou
|
|
|
141 |
C |
p. 199-208
|
artikel
|
| 8 |
Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review
|
Bolhuis, Karen
|
|
|
141 |
C |
p. 225-238
|
artikel
|
| 9 |
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
|
de Joode, Karlijn
|
|
|
141 |
C |
p. 171-184
|
artikel
|
| 10 |
ERCC3, a new ovarian cancer susceptibility gene?
|
Stradella, Agostina
|
|
|
141 |
C |
p. 1-8
|
artikel
|
| 11 |
Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity
|
Mazzarella, Luca
|
|
|
141 |
C |
p. 218-224
|
artikel
|
| 12 |
Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018)
|
Cottu, Paul
|
|
|
141 |
C |
p. 209-217
|
artikel
|
| 13 |
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
|
Muñoz-Unceta, Nerea
|
|
|
141 |
C |
p. 193-198
|
artikel
|
| 14 |
How to manage patients with corticosteroids in oncology in the era of immunotherapy?
|
Aldea, Mihaela
|
|
|
141 |
C |
p. 239-251
|
artikel
|
| 15 |
Identification of nephronectin as a new target for IGF1 action
|
Sarfstein, Rive
|
|
|
141 |
C |
p. 115-127
|
artikel
|
| 16 |
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
|
Rubio-San-Simón, Alba
|
|
|
141 |
C |
p. 82-91
|
artikel
|
| 17 |
Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer
|
Lerman, Jacques
|
|
|
141 |
C |
p. 143-151
|
artikel
|
| 18 |
Infectious complications in patients treated with immune checkpoint inhibitors
|
Karam, Jean-Denis
|
|
|
141 |
C |
p. 137-142
|
artikel
|
| 19 |
Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour
|
Cassier, Philippe A.
|
|
|
141 |
C |
p. 162-170
|
artikel
|
| 20 |
Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time
|
Hulshof, Emma C.
|
|
|
141 |
C |
p. 9-20
|
artikel
|
| 21 |
Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study
|
Kang, Sokbom
|
|
|
141 |
C |
p. 185-192
|
artikel
|
| 22 |
Repurposing anticancer drugs for the management of COVID-19
|
El Bairi, Khalid
|
|
|
141 |
C |
p. 40-61
|
artikel
|
| 23 |
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
|
Lièvre, Astrid
|
|
|
141 |
C |
p. 62-81
|
artikel
|
Tijdschrift beschrijving